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Ab t ract 
Knov\ J dgc o C the frequencie and the phenoty pe of ABO and rhe u ) stem i 
v cr) important for bl od bank and tran fll ion service pol ic ie . The objectiye of 
thi 'tud) \\ a to determ ine the frequenC) of  BO. Rhesus ph notyp and most 
probable genot) pe in in area ( U  E ) . The studied group consi ted of -00 locals 
of both gender from di ffer nt age groups (17-58 years old ) .  BO and Rh-br 
ph n ty pe react i,  it) were detem1 i ned using conventional tube method and gel 
technology , molecular technique were also appl ied.  Our study shows the 
d i  'tribution or  A BO phenoty pe wa a fol lows :  0= 56%. A= 26.2%. B= 14.2°0 and 
AB= 3.6°'0. The d i stribution of Rh ant igens \va a fol lO\v : D= 90.4 %. = 76.2?0. 
E= 27.2° 0. = 71.6°0 and e= 97.8%. And the di stribution of rna t probable genotypes 
\\ a as fol lows :  R 1  1- 29.8°'0. R1 R 1  = 28.4%, R 1  R2= 16.8%. n'= 8.4%. R2 r= 8.2%. 
Ro 1'=5°'0. R2 R2= 2.20 0. and r'r= 1.2%. Our study showed that the mo t frequent 
antigen amongst fi ve major ant igens of Rh s stem was RhD while the least common 
v, as E antigen. We developed an innovat i ve method that combines molecular 
anal v i and ero logical testing of Rh genes to be appl ied in  blood bank environment 
a i t  is con idered a a tir t study done in the area. This approach could improve 
pat ient care and transfusion outcomes by reduc ing al lo immunization. The chal lenge 
l ies in i ntegrating uch testing i nto blood bank envi ronment. tandard izing methods, 
obtain i ng Food and Drug Admin istration approval for label ing donor units. and 
enhancing  information sy terns to i ncorporate and use th is  new information 
effectively .  
Keywords: Frequency. ABO blood group, Rhesus system. phenotype, most probable 
genotype. UAE.  AI  A in .  
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C hapter 1: I n t roduct i o n  
Literat u re re\'ie\\ 
1.1  A BO Sy tern 
The A BO blood group y tern. \\ hich wa the fi r t human blood group ystem 
to be d i scO\ er d by Land t iener in 1 90 1  (Land teiner. K. ( 1 900 ).  Boskababy M .. et 
a 1 .  ( 2005 ) .  & I) io la. 0 . .  et a l .  (20 1 1)) . remains the most important in transfusion 
practice.  Land t iener named the first t\\ O blood group ant igens and B using the 
fi rst tv" o letter of the alphabet, \,yh i le  the red blood cel l s  ( RBCs)  not react ing with 
both antigen \\ ere cal led type C.  Later in 1 9 1 1 ( Bashwari .  L .. et a1 . ( 200 1 )). Von 
Dungern and Hi z[eld used the letter 0 to name the RBCs not react ing with both 
ant i - and ant i -B .  and the term AB for RBCs reacting with both ant igens. Therefore. 
there are four main group as hown in table ( 1 )  ( M ouhau . H . A  .. et a1 .  (20 1 0) .  & 















Table 1: The four ABO blood types ( phenotypes) and their possible s ix 
genotypes : 
Determi nation of  these four groups i n  humans depends on three a l le l ic  genes 
located near the t ip  of the long arm of chromosome 9 as shown in Figure 1 
( Boskababy M . .  et a1 . ( 2005 ). & Nagariya. S .  ( 20 1 3 ) ) .  Two al le les \ hich one of them 
encodes an enzyme which produces the A substance. another B substance: and when 
both of these a l le les are present in a heterozygote both carbohydrates are made. The 
thi rd a l l  I e. . beha\ e e sent ia l l )  a a "nul l" al lele, producing neith r 
2 
nor B 
ub lance (J hn . Dac i , et aL ( 1 98-+ ) ) . The pre ence of  and B gene re u l t  i n  
addi t ion of  ugat"" t the H antigen to produce the and B antigen; 1 -acetv l D-� -
galacto ami ne in  the ca e or  A g n and D-galactose i n  th ca e of the B gene a 
h \\ 11 i n  figure (2 )  ( R ichard H .  Walk r. ( 1 990 ).  & Hoso i .  E .  (2008 ) )  . 
<"I <"I ,.- M <"I ..-: ..-: <"I 
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C"> ..... <"I C\J "" C'C) � C'C) "" <"I � � 
..... g � ..... M ..... ;;1, B- � � i ..... a- a- a-
Figure 1 :  10 lecular location of ABO gene in  chromosome 9,  Th ABO gene is  
located on the long (q ) arm of chromosome 9 at  posit ion 34.2. as per 
http ://ghr.n lm .n ih .gov/gene/ BO 
[RB ]---0- GLU - GAL 
I I " tem" carbohydrate (="H" antigen) 
NAe FUC 
[RBC]---O- GLU - GAL - GAL 
I I substance B 
Ac FUC 
[RBC]---O- GLU - GAL - GAL 
I I ub tanee A 
Ac FUC NAc 
Figure 2: The structure of the blood group substances A and B which 
repre ent two modified fom1s of a stem carbohydrate pre ent on red b lood 
cel l s .  ( G L U :  gl ucosamine, GAL:  galactose or galactosami ne, F C :  fucose 
and NAc represent an -acetyl group) .  
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I n  tran I' u ion medic ine detem1 ination of the e antigens \ ery Important 
bccau e of th regular occurrence of the antibod ie anti-A, and ant i- B and anti-AB 
(table2 ) react i \ e  at 3 71l • in per ons ,-,.ho red cel l s  lack the cone ponding antigen , 
'0 that i f  t ransfu ion were to be g i\ en \-\ ithout regards to ABO groups, the 
tran 'fu ion r act ion \-\-ould occur and that ma! be fatal ( K le in ,  H.G . . et a! . (20 1 -1-a » . 
Gro u p  Su bgro u p  Ant igen on red cel ls  Ant ibodie 
(agglu t i n i n) in  seru m 
Anti-A 
0 None Ant i -A I  
Ant i -B 
Anti-AB 
A +AI Ant i -B 
2 A 
B B Anti-A 
Anti-AI 
AB A l B  A + A l  + B i l  
A2B A+ B 
Table 2: Antigens and Antibodies i n  the ABO system 
1.2 M o lec u l a r  basis of A, B and A B  blood gro u ps 
1.2.1 Structu re a n d  specificity of A and  B-glycosyltra nsferases 
The A BO gene comprise seven exon and encodes a polypeptide of 35-1- amino 
aci d  with a hart ami no term i nal tran -membrane segment and a large globular 
cytopl asmic domain contain i ng the cata lytic s i te .  The cytoplasmic domain i s  
posi tioned i n  the l umen of the Golgi  ( agariya, S .  ( 20 1 3 ) . As mentioned earl ier that 
the N-acet) le D-galactosami ne alpha l i nked to the non-reducing end of 
o l igosaccharide chains defines the A ant igen, and that D-galactose alpha l i nked to the 
non-reducing end of o l igosaccharide chains defines B ant igens. ( Morgan, W.T, et al . 
(2000)) .  The A-transferase catalysis the transfer of N-acetyle D-galactosami ne 
( Gal  Ac)  from U DP-GaINac to H antigen acceptor. whi l e  the B- transferase transfer 
4 
D-galacto c ( Gal ) from fOP-Gal to the I I  antigen acceptor. The e t\.\ O  tran fera e 
d i ffer b} onl}  four ami no acid  r idue 1 76, 23 - . 266. and 268 i n  the and B 
rcspcct i \ e l )  ( Patenaud . .  r.. et a1 .  (2002 ) .  & ojavan, M ., et a1 . ( 20 1 2 ) )  a shown i n  
table C). The trans1' ra e i organized in  two subdomain : one subdomain compri es 
the ami no term i nal region and recognize the OP-sugar donor and the other 
carbox) terminal ubdomai n provide the acceptor b inding site .  Both ubdomains are 
eparated b) a cleft contain ing the active site. Residues 266 and 268 are located in  
the  act i \ e site of  the enzyme and int1uenc donor recognit ion.  The B tran [erase 
re idue 1 et266 and la268 are bigger than the corresponding re idues i n  the A 
tran f ra and re trict th s ize of act ive si te c left to exclude UDP-Gal Ac 
( Patenaude, .L et a! . (2002 ) ) .  Residues G I ) 2 3 5 Ser and Leu266Met influence 
receptor b inding( Lett . lA. ,  et a 1 .  ( 2006) ) .  I n  the absence of donor or acceptor the 
enz) me adopt an open confirmat ion which leave the donor and acceptor ites 
exposed to solvent .  The c losed confirmation i requ ired for catalysis to occur. 
B i nd i ng of H ant i gen acceptor results in a clo ed confirmation in which the fi nal n ine 
carbox. terminal  res idues form hydrogen bonds with L-fuco e res idue of  H ant igen 
and UDP ( A l faro. lA. ,  et al . (2008 ) ) .  
A m ino  1874 87 1 56 1 76 235 266 268 354 
acid 
AJ-J Arg Pro Pro Arg Gly  Leu G ly  Arg 
AJ-2 Arg Pro Leu Arg Gly  Leu GIl' Arg 
B Arg Pro Pro G ly  Ser Met Ala Arg 
OJ Deletion 
of G at 
nt 26 1 
02 Leu Ser Gly  Arg 
A2 Leu Deletion of C 
at nt 1 06 1  
B Gly Gly  Met Ala 
CisAB Leu Ser Ala 
Table 3:  D i fferences in amino acids (aa )  between various al le le of the ABO 
gene ( Daniels .  G .  (20 1 3 ) )  
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ABO phen t) pe re u l t  from i ngle nuc leot ide deletion or ub t i tution i n  the 
penul t imate cod n changing the reading fram 0 that the tran fera e produced has 
an c'\tra 2 1  amino acid' at the carboxy tem1 inu ( table 3 ). th is  affect the tructure of 
the enz) me u fficient l) to change its spec i ficity and act i \ it) (Yaz 1", l.l-L et a1 . 
(200 8 ) ). s an example. in  the ca of ci B (a  group AB father and a group 0 
mother ha\ e an AB ch i ld ) .  it \ '.ould appear that ub t i tut ing one or the other of the 
crit ical res idue in  the A or B transfera e al low access to both DP-Gal and UDP­
Gal c. but reduce enzy me act ivity.  as the phenotype has weaker A and B antigen 
expre ion than normal ( Patenaude. .L et a l .  (2002 ) ) .  
1 .2 .2  Com petit ion between A and B tI'ansferases 
Subject who ha\ e both A and B al le le sho\ d imin ished expre sion of both A 
and B ant igens because A- and B- transfera es act upon the same precursor sub lance 
( Daniel . G. ( 20 1 3 ) ) .  Thu . A l B  red cel l s  have less A than A l  ce l l s  and A2B cel l s  
I es  A than A2 cel l . im i larly. B i s  s l ightly less strongly expre ed  i n  1 B than B 
cel l s .  I n  some cases. red cel l s  of  genotype A l B  may behave as A2B due to an 
interference with express ion of A l  by a strong B al le le .  (Daniel s .  G. (20 1 3  ) ) .  
1 .3 M olecu lar  b a  i of b lood gro u p  0 
The absence of  an act ive ABO glyco yl transferase results i n  the blood group 0 
phenot) pe. ubject \\7 i th 0 phenotype i nherited an A l  tran ferase gene in  Vvhich 
nucleotide 26 1 (deIG) i n  exon 6 i s  deleted ( Hosoi .  E .  (200 8 ), & Daniels .  G .  (200 1 ) ) .  
T h i s  nucleotide deletion changes the reading frame resul t ing in  translation of an 
i nactive protein "\\i th an altered amino acid  sequence after amino ac id  88 and 
term i nati ng at ami no ac id  1 1 7 so that large cata lyt ic  domain is absent ( Hosoi .  E. 
(2008) .  & Danie ls .  G .  (200 1 ) ) .  There are several rare 0 al le les result ing from 
d ifferent m utations which create a translated protein  lacking glycosyl transferase 
6 
act i \  i t� (YaLer. i'.U r.. et a! . (2008 » ) . The e rare 0 al le le  create no c l in ical problem 
\\ hen com ent ional ero logical method of ABO t) ping i employed. but pro\ ide 
considerable chal lenge � r D -ba ed method of BO typing becau e the 
mutat ion occur in an 1 or A2 transfera e gene and 0 ind iv iduals could mistakenly 
be t) ped a A if the D ba ed m thod emp loy ed i s  not configured to detect these 
\ ariant 0 al le le ( K lein. I I .G . .  (a1 . ( 20 1 4b) . & tOIT) , R . .  et a! . (2008 » )  
1..4 R h  ),stem 
Th Rhe u ( Rh )  b lood group y tem v. hich \\a d iscover d in late 1 940' by 
Le\ ine and tet on ( gre. P . . et a1 . ( 1 99 1 ) con idered as the most polymorphic of 
human red b lood group ) tem. consisting of at lea t 5 1  independent antigens ( bou­
labaL . .  et al . ( 2003 » making it  the most complex RBC ystem. This system 
considered as the econd and next to the ABO, is the most c l in ical ly  s ign i ficant 
) tem in t ran fusion medic ine. The c l in ical importance of the s) stem is a 
consequence of  the fact  that the Rh-negative indiv iduals are relatively eas i ly  
t imulated to form immune ant i-D ant ibodies through e ither pregnancy fonning the 
hemolytic di ea e of newborn ( H DN ). which is mo t commonly the result of the 
destruct ion of infant's D-posit ive red cel l s  b) I gG ant i -D ant ibodies ( John V. Dacie et 
a 1 .  (1984» . or through transfusion of red cel l s  to Rh-negative individuals .  This 
ensured i ts  cont in ued use in c l in ical invest igat ion .  
1A.1 Molecu lar  b iology of the  R h  system 
I t  was found that the biomedical studies of the Rh proteins could not be 
possib le d ue to the h drophobic nature of this protein, despi te their c l in ical 
importance. For that. the molecular basis of most Rh antigens has been determined, 
and the structure of RH genes confirmed its polymorphic nature ( Westhoff, CM. 
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(2004 » . peci fi call ) . the om entional Rh antigen are encoded by t\\ O gene . RHD 
and R I  I E. but numerou gene com er ion e\ ent bet\\ een them create h) brid gene . 
The re u l ting no\ el h) brid proteins containing region of RhD jo ined to RhCL or 
the c 11 \ er e. generate the myriad of di ffer nt Rh antigen ( hanna. D.C . .  et a l .  
(20 1 3 ). & A\ ent. " . D  .. et a l .  (2000» . 
1 .... . 2 Term inology 
Cunent Rh lerminolog) attempts to di stingui h the genes and proteins from the 
antigen . \\ hich are referred to by the letter de ignations. D. C, c, E. and e. capital 
letter and i tal ic are used \\ hen refening to the RH genes. \'\'hich inc lude RHD. 
RHCE.  and RH G ( We thof[ c ' M .  (2007 » . The d i fferent a l le les of the RHCE gene 
are de ignated R Hce. RHCe. and RHcE. according to which ant igens they encode. 
The proteins ar indicated as RhD and RhCE according to peci fic ant igens they 
carr) . Rh haplotypes are designated Dce, DCe. DcE. or ceo Ceo cE when referring to 
a peci fi c  CE haplotype ( Hassan. F . M  .. et al . (20 1 3 » . 
1 .... . 3 R H  genes and  R h  p roteins 
The expression of the Rh factors i contro l led by two genes. the RHD and 
RHCE which l i e  in c lo e proxi mity on chromosome 1 and encode 4 1 6  amino acids 
Rh proteins : one gene codes for D antigens and other gene for CcEe ant igens in 
\'arious combinat ions  (Wanger. F . F  .. et al. (2000» as shown in figure 3 .  The Rh 
genes are a source of s ign i ficant d iversity favored by the opposite orientation of 
R H D  and R H C E  genes. Each gene has ten exons  that are 97% identical and encode 
proteins that d i ffer by 32 to 3 5  amino acid . The RH genes are separated by a stretch 
of around 30 Kb which inc ludes another gene ( S M P 1 ) ( Wanger, F .F . ,  et a l .  (2000» . 
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fhe D g ne I '  Danked b) t\\ O 9-Kb regIon o f  homolog) denoted rhe u boxe . 
( figure '" ) 
C h romosome "1 
RHCE 
Genes ., 2 3 4 ts 8 7 8 9 ., 0 
RHO 
R h  p <> s I U 'Ve _ "  
R h  "", eg a t l 'Ve d _ l_ t_d RI-#c:# 
- -
RHD 
" ......... . 
" 2 3 4 5 6 7 8 9 "1 0  
RHCE 
<:lei ... C_. c:.8. !lOr c e  
Fio u re 3: chematic d iagram of  RHC E  and R H D  gene and their proteins. The 
po i t ion and orientat ion of the genes and the Rhesu boxes are indicated by open 
arro\v and triangles. re pective ly .  The exons are shov./I1 as ert ical bar , and their  
exon numbers are indicated. The 2RH genes have opposite orientat ion,  face each 
other \\'i th th ir 3 8  end . and are separated by about 30 000 bp. A thi rd gene, MP L 
has the same orientat ion as R H D  and i posi t ioned between R H D  and RHCE.  The 
R HD gene is fl anked on both sides by the 2 h ighly homologous Rhesus boxes. which 
are noted by ( b) .  All exons are shorter than 200 bp, \ i th the exception of the RHD 
and MPI  3 8  terminal exons.  
l AA Rh y tern nomenclature 
The Rh s tem \ ould become notorious for its complexi ty with numerous 
ant igens and mul tip le  nomenc latures defin ing it. Two method of Rh notat ions have 
been described. The C D E  notat ion of F i sher and Race described encod ing of Rh 
ant igens by three c losely l inked loci ( G uzman, R . M . S . ,  et a 1 .  (20 1 0 » . Recogn izable 
haplotypes regarding th is  notat ion are C De. c DE, cDe, C DE,  cde, Cde,  cdE and CdE. 
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rhe a l temat i \ e Rh-hr notation of  Wiener \\ as ba ed on the h) pothe i of mUlt iple 
al le les at a s ingle locus. (Kle in . I I .G . .  et al . (20 l 4c ) ) . ee table -+ .  
F i  her ShOJi notations 
C De R J 
cde r 
c D E  R2 
c Dc R(I 
C\' De R I \\ 
cdE r" 
Cde r '  
C D E  R' 
CdE r) 
Table 4: Fisher nomenc lature of Rh gene and the corresponding short 
notat ions ( Rudmann. . Y .  (2005 ) ) .  
1 .4.5 Variat ions of R h D  
Some variant Rh phenotypes are caused by exchange of  genetic materials 
between the t\'\' o genes or from m issense mutations.  The Rh variants can weaken 
expreSSIOn of the common antigens. produce paliial  ant igens, generate lo\\- ­
pre\ alence ant igens, and result i n  absence of  high-prevalence ant igen ( Kappler­
Grati as. . .  et al .  (20 1 3 ) ) .  These variants al leles encode Rh protei n  with ami no acid  
changes that cannot be d ist inguished sero logical ly,  but  can be recognized by the 
immune system as foreign.  Some patients are at risk for production of antibodies to 
both the RhCE and RhD protei ns. a serious and potential ly  l i fe-threatening 
compl icat ion .  The chal lenge i to i nst itute molecular screening of  minority donors to 
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de\ elop a regi tr) r unit that are genot) ped for the e \'ariant . Thi i crit ical to 
meet the tran fusion need of th se a l lo immunized and often cri t ical l y  i l l  patient . 
e pecial l y  a rare O-negat ive unit are in  ver) l imi ted uppl) and are not alwa) 
compatible .  
I A.S. l D- Posi t iH var iants 
10  t ind i\  idual \\ ho are O-posit ive have identical R H O  equence . but 
approxi mately  20 0 have al tered al leles that encode proteins with ami no ac id changes 
or have h) brid al le le encod ing protein with part of RhD fu ed to RhCE. or vice 
\ er a ( Kappler-Gratias. . . et al . ( 20 1 3 ) ) .  These altered or hybrid proteins wi l l  resul t  
i n  forming \\ ak 0 ( reduced expression of D antigen) and/or part ia l  0 (al tered D 
urface epitopes ) ( F lege l ,  W.A . .  et a ! .  ( 2002 ) ) .  
l A.S.2 D-Negat ive varian ts 
Antigen of the Rh blood group sy tern are encoded by two homologou gene. 
R H D  and RHCE.  that produce two cel l  membrane proteins .  D-negat i \ e red cel ls lack 
the 0 protein .  and a l loant i -D  consists of antibodies to a variety of epi topes on the D 
pol )  pept ide. There are three common genet ic mechani sms responsible for D negative 
phenotype:  delet ion of RH O that results from chromosomal m i sa l ignment at meiosis 
and subsequent unequal crossing over between the rhe u boxes ( ( F legeL W.A. ,  et al . 
( 2002 ) & Wanger, F . F  . .  et a 1 .  ( 2000))  ( F igure3 ),  a pseudo gene R H D contain i ng a 3 7  
b p  insert and 1 or 2 stop codon. and a hybrid RH D-CE-D that probably produces an 
abnormal C ant igen but does not produce a D antigens ( Westhoff. C . M .  ( 2007),  & 
Toui nssi .  M . ,  et a 1 .  ( 2009) ) .  These three types are shown i n  fi gure (.f) Know ledge of 
Rh phenotypes and variants in  given population is  re levant for better plann ing and 
1 1  
management o f  a b lood bank:  to find compatible b lood for patient needing mult iple 
b lood tran fu ion , v" hich would re o lve the blood tran fusion ne ds of recipient . 
l?J I( 'E RHIJ 
7 P ,n crt t p cod n 
• • 
- po i t i  e 
D - n egat t c 
D- n egat i e 
( ') e' 
D - n egat i e 
RHD de l e t i o n 
Figu re (.t) : Repre entation of the genomic rga n i zation of the O-posil ive hap lot} pe and 3 D­
negat i \  e hapl  t} pes. W h i te boxe ind icate R H C E  exon and b lack ind icate R H O  exon . 
( inglet n, B.K., et a l .  ( 2000». 
1 .5  I n heritance of red cel l  antigens 
Two imi lar set of  chromosome ( one set inheri ted from each parent)  are 
present in a l l ce l l  of  the body e cept the genn cel l s. Each set i s  composed of 22 
auto omes and one sex chromosome ( the total number of chromosomes i s  46) .  The 
ex c lrromosomes in the female are equal in s ize and are termed x c lrromosomes 
whi le in mal there i one x c lrromosome and one much smal ler chromosome, termed 
Y ( Daniel  D .  Chi ras. (2008 ) ) .  
The segment of chromosomal 0 A which detennlnes a part icular polypept ide 
defin ing the gene, whi le the a l ternative forms of genes at a part icu lar locus are 
termed al leles, for example A. B ,  and 0 ( Ta lukder, S . ,  & Das R .  (20 1 0) ) .  An 
ind iv idual may be homozygous (e .g. AA) or heterozygous (e .g .  AO) for a l l  genes 
carried on auto omes. Whereas the term genotype is used for the sum of inh eri ted 
a l le le  of a part icu lar gene, for example AA. and AO phenotypes refers only  to the 
recognizable product of the a l le les ( Hosoi ,  E. ( 2008)  & Danie ls .G .  (200 1 ) ) .  As 0 has 
no sero logical l y  recogn i zable product, the genotypes AO and AA both have the 
phenot) pe . al though 0 ha no recognizable product. the D T 
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tru ture of thi 
s i lent al lele di ffer on l)  l i ght ly from that of and B al le le ( Danie l . G.  CWO l )  & 
10uhau . I I . . .  et al . (20 1 0 ) ) .  I fo\\ e\ er. in the Rh ystem. the gene D ha no al lele .  
t the corre ponding p i t ion on the homologues chromo ome. there i either 
anoth r D g n or a D gene alter d in uch a \va) that D polypeptide cannot be made 
(We thoff. . M .  ( 2007 )  & rouin i .  M . .  et a l .  ( 2009 ) . 
Gene that are far apm1 on the same chromo ome. [or example Rh. or genes that 
m'e carri d on di fferent chromosomes are inheri ted independently and the antigens 
the) determine are aid to belong to di fferent blood group system ( Westhoff. C . M .  
(2007)  . In o m e  ca e . more than one protein i produced from a Ingle gene and 
thus one a l le le  determine more than one polypept ide (Talukder. S . .  & Das, R.  
(20 1 0» ) .  Red ce l l  antigens are ei ther proteins or carbohydrates� the protein ( Rl1 ) are 
the d i rect product of genes. but tho e that are carbohydrate ( A )  are determined 
ind i rect ly by enzyme (glycosyl transfera e) that are the gene products. These 
enzyme transfer the appropriate sugar. determining speci fici t  on to a structure 
\\ hose synthesis may be detenl1ined by one or more unrelated genes. In most cases 
there appears to be a imp Ie conespondence between genes and ant igens. so that i f  a 
person inherits a given gene the ant igen can be detected on the red cel l s  ( agariya, S .  
( 20 1 3 )) .  
1.6 Gene (a l le le)  freq u ency 
Gene frequency i s  s imply the frequency of  the al le le in the population as a 
whole :  the term al le le frequency would be more prec i se but i t  i s  not general ly  used 
( Guzman .  R. M . . . et al . ( 20 1 0 ) ). From a knowledge of the frequencies of the genes 
(a l l ele ) in a b lood group system, phenotype frequenc ies are readi ly  derived. In 
13  
di fferent race the propol1ion of ind i \  idual belonging to a part icular blood group 
\ ane \\ id  1 ) . Both ABO and Rhe us blood group \ ari s in incidences in d i fferent 
populat ion .  There are man) studies done al l  oyer the \\ orid to determine the 
frequ nc) of A BO and rhe u phenotype in di fferent populations.  
1 .  7 Frequencie of A BO and Rhe u in d ifferent popu lation : 
With re pect to ·tudies in AE. and to our kno� ledge. Taha. l Y .  20 1 2 ). has 
e\ al uated the frequency of Rh phenot; pes and the most probable genotypes in Kalba 
regIOn. AE.  he te ted 66 1 amples randomly wi thout considering the nat ional ities 
u ing tub method . \\ h i le  bou-Jabal . A e t  al ( 2003 ), stud ied a group of 1 000 
Jordanian donors using the ame methods. Both of them concluded that stud) ing 
blo d group phenot) pe di  tribution i very important for blood bank and transfusion 
ervice pol ic i  s .  Al 0 tudying the Rh-hr phenotypes and genotype i s  of val ue in 
soh ing problem regard ing incompat ib i l i t ies. im'e t igat ion of autoimmune hemolytic 
anemia. and in tudies on the origins and mo\ ements of populations .  
Hov,:ever. Bashawri . L . .  e t  a l .  ( 200 1 ), and GhasemL . .  et al ( 2007), studied the 
fJ:eq uency of A BO and Rh blood groups in the eastern region of Saudi Arabia and in 
middle schoo l students of Yazd Province ( I ran) respect ively .  Bashawri studied 5 739 
male potential  b lood donors during two different periods ( 1 985 - 1 989 and 1 995-
1 999). whi l e  Ghasemi examined 2000 students using s l ide method considering the 
place and date of b i rth .  They concluded that, the knowledge of the frequencies of the 
d ifferent b lood group is very i mportant for blood bank and transfusion service . And 
a lso it i s  important for c l in ical studies (d i sease as oc iat ions)  as wel l  as for population 
genetics stud ies.  In addi t ion to that. Ghasemi found that, there i s  no re lat ionship 
between ABO blood group and sex, place of b i l1h and inseminat ion season. They 
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al 0 con firmed that BO and Rh antigenic structure d i ffer bet,'. een region and 
nat ion . 
Determinat ion of the d istribut ion of BO and Rh b lood group in  d i fferent 
region and nat ion help i n  comparing the di tr ibution trend of the e blood groups 
and thi ' v" hut Jurf. L .  ( 20 1 0 )  did \",hen the) determined the di stribution of BO 
and Rhe u b lood group in Kurds b) studying group of total popu lat ion of 5323-+ 
\\ bo e A BO and Rhesu blood groups were determined by standard method during 
a period of about 5 years ( 2005- 2009 ) .  He concl uded that the blood group 0 is the 
commone t b lood group. fol lowed by A. B. and AB .  By comparing what he found 
\\ i th other populat ion he found that the di tr ibution of ABO and Rh blood groups in 
Kurd ha s imi lar trends to the n ighboring countries. and appears to be intermediate 
between eastern ( ian) and we tern European (Caucasian )  data. 
In addi t ion of the above ment ioned benefits. b lood transfusion centers strive to 
provide b lood products that are m icrobiological ly  safe and compat ib le  with recipient 
blood characterist ics .  To achieve this.  pre-transfusion screening at t\VO levels is 
requ i red. The tI l' t level involves b lood cel l ant igens .  A total of 339 blood group 
spec ific i t ies incl uding 297 in 33 systems ha e been recorded by the International 
oc iet) B lood Tran fus ion ( I S BT)  ( Reid. M . . et al . ( 20 1 2 ) . Because the ABO and 
Rll ant igens can be immunological ly  ign i ficant due to presence of natura l  ABO 
ant ibodies and strong i mmunogenic i ty of RHO ant igens. systemat ic ABO-RllD 
typing is necessary . The second level of screen i ng involves i dent ificat ion of Rh-Ke l l  
ant igen ic  profi les and.  to  a lesser extent .  Kidd. Duffy. and Ss  phenotype (S i ransy 
Bogu i .  L . ,  et a l .  ( 20 1 4 » . This pre- screening is necessary depending on the patient, 
pathol ogy. and r isk of  a l loimmun i  ation .  
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In addi t i  n t en uring transfu ion afet) . awar ne of ant igen freq u  ncy In a 
g i \  en population i imp0l1ant in defin ing product requirement and minimum tock 
Je\ els .  G i \ en the high \ ariabi l i ty f red c I I  antigens. b lood tran fu ion centers must 
detemline ant ig  n frequencie in the population that the) erve. Con equently.  the 
a im of th is  stud) wa to deteml ine the frequenc) of ABO. RJle u phenotype and 
mo t probable genot) pe and the type of the RI I D  negative \ ariants among AE 
nat ional in I Ain area. \\ hich can be appl ied in practice for a rapid and efficient 
identi ficat ion of  b lood donors and the immed iate e lection of  needed compatible 
blood un i ts .  t the arne t ime.  this study \\-i l l  help in mapping a nat ional status for 
future reference through preparing database for the blood banks and hospitals b lood 
transfu ion c nler . A lso th i s  study can dec ipher di vers ity or un iquenes of the UAE 
more pec ifica\ J )  Al in populat ions structure .  
1.8 Background  of U n ited A ra b  E m i rates ( UA E )  
The Uni ted Arab Emirate ( UAE) i s  part of  the Gu lf  cooperat ion Counci l  
(GCC)  which cons ist o f  ix  gul f  countries inc l uding the k ingdom o f  Bahrin. Kuwait 
Qatar. k ingdom of audi Arabia, and Oman .  In addi t ion the UAE is located in the 
castem part of the Arabian Pen in ula extend along part of the Gu lf  of Oman and the 
southem coast of the Arabian Gulf. The UAE is a constitutional federat ion of seven 
emirates :  Abu Dhab i .  Dubai . Shmjah, Ajman.  Umm al-Qaiwain. Ras a l -Kll ai mah and 
F ujairah. The federat ion was formal ly establ i shed on the second of December 1 97 1 . 
UAE occupies an area of  7 1 023 .6  Sq . Km. along the south-eastem t ip of the Arabian 
Pen insula .  As shov"n in figure ( 5 ). Qatar l ies to the west, Saudi Arabia to the south 
and west. and Oman to the north and east. The UAE l ies betv.:een lat i tude 22. 3 5° . 
2 .25° north, and longitude 5 1 . 3 1 ° . 57 . 1 ° east .  ( UAE stati stical center. 201 0). 
Furt hermore. the capital and the l argest c i ty of the federat ion in the UAE i s  Abu 
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Dhabi .  \,\ hich accounts for 87  percent of the A '  total ar a.  bu Dhabi consist of 
se\ eral citie and Al In on f them . 
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Fig u re 5 :  Pol it ica l  and Adm i n istrative Map of U n ited A rab E m i rates 
http://v.'\vw.nat ionsonl i ne.org/oneworldlmap/united arab emirates map.htm 
1 .9 Back G round  of Al  A in  Area 
Al Ain  is the econd largest c i t ,  in the Emirate of Abu Dhabi and the fourth 
largest c ity i n  the Un i ted Arab Emirate . With a populat ion of 568,22 1 (20 1 0) ,  it is  
l ocated approx imate ly 1 60 k i lometres east of the capital Abu Dhabi and about 1 20 
k i lometres south of  Dubai . Al  Ain  has a higher proportion of Emirat i nationals than 
elsewhere i n  t he country, but the majority of its residents are expatriates part icular ly 
from the Indian sub-cont i nent. Many people are from Bangladesh, Pakistan and some 
from Afghani stan. There are fewer other expatriates than i n  the l arger centers of Abu 
Dhabi and Dubai . ( A l  A i n  munic ipal i ty s i te ) .  
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1 . 1 0 F requency of the donor i n  the populat ion 
The group from the population \\ ho are qual i fied to be blood donors consi t of 
h a l th) adul t  ag d 1 7-65 y ear . The highest frequency of donation in  the \\.:orld 
cone pond to about 1 0% of the population el ig ible to give blood donat ing once per 
l ear. ( Ha ig, . ( 1 99 1 )  & L inden, J . V  . .  et a l .  ( 1 988) ) .  The num ber of units col lected 
per Al Ain populat ion dur ing the 3 year ( May 20 1 2- Ju ly  20 1 5 ) is shovm in table 5 .  
Lo e from outdated red cel l s  accounted for the same period was 5 70 ( 1  % from total 
col lect ion)  ( A R B B )  of  th supply but gi yen the fact that red cel l can be transferred 
only to compat ible rec ipients. the number of usable units  outdated appears to be 
extremel) low ( AARBB tat i st ics 20 1 5 ) .  
M ay-Dec Jan-Dec Jan- Dec J an-J u ly 
20 1 2  20 1 3  2014 2015 
Other N at iona l ity 67 1 3  1 1 562 1 2267 6784 
U A E  Nat ional ity 2989 4507 5054 2 503 
Total 9702 1 6069 1 73 2 1 9287 
Table 5: num ber of \ hole blood units col lected i n  Al Ain Regional b lood Bank 
during three years ( M ay 20 1 2  - Jul y  20 1 5 ) .  
1 . 1 1 Blood u t i l ization a n d  shortages 
Despite the constant r ise in col lection (table 5 ), b lood col lectors report freq uent 
shortages and emergency appeal s  for blood are d isturbingly common. Some 1 5 ,000 
units of red cel l s  are col lected annual l y  in AARBB and the numbers continue to rise. 
(AAR B B  20 1 5  stat i st ics ) .  With  the current she l f  l i fe. the b lood supply  more c losely 
resembles a p ipe l ine than a bank or reservoir.  A few days of under col l ection can 
have a devastat ing effect on supply .  There are l it t le general agreements about what 
constitutes a shortage. Measures of postponed surgery and transfusion,  as wel l  as 
i ncreased rates of RhD-Posit ive transfusions to RbD- egat ive rec ipients pro ide 
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'ome indicat ion of  hortage at th treatment le\ eJ ( We thoff. C . :-' L  et a l .  ( 2008 » . 
B lood ut i l ization ma)- require to reach stead: -state or higher to coyer the hortage in 
bio d cel l  through contro l l ing the pattern o f  donat ion and usage . Ordinari h .  more 
blood i '  donated b) younger age groups. \\ hereas more i s  u ed b) the elderly 
( cobain. T . . et al . ( 2007 )  \ ariat ion in RBC u e per capita among countries can be 
explained large l)  by the age di tribut ion d i fferences of the populat ion rather than by 
the d i fferent nat ional treatment standard . ( A l i .  A. ,  et al . ( 2009) ) .  ubstanl ial 
resource are requi red to be invested in donor recruitment and retention or methods 
need to be adopted to sen e th changing population demographic and reject the 
b lood hortage t become a way of  l i fe.  These methods may inc lude detem1ination 
of the frequenc) of  the most s ign i ficant red cel l  antigens ( ABO & Rh)  to ensure safe 
tran fu ion to rec ipients.  A'v areness of antigen frequency in a gi en populat ion i s  
important i n  defining product requ irement and min imum stock requ i rement to 
o\ ercome b lood shOliages.  0 in this tudy, we detern1ined the frequency of  ABO. 
Rhesus phenotype and most probable genotypes and the types of Rh D negat ive 
variant among UAE nationals in Al  Ain area. 
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1 . 1 2  Object iH 
' ince there i no data a\ ai labl on the BO and Rh frequencie in I Ain area. 
this tud) v, i l l  be f \ al ue in oh ing problems regarding blood transfu ion 
incompat ib i l i t ie . AI  0 the d temlinat ion of Rh( D )  anti gens w i l l  help in a\ oiding 
the ri k of  forming hemol)1ic d i  ea e of ne\', born or for neonatal l lo-immune 
thromboc) topen ia  through det rmining the paternal al lele inheri ted by the fetu . 
10reo\ er, B lood bank usua l ly  has a problem of ever-changing stock po i t ion and i t  
i \ er) d i fficu l t  t o  predict th incidence of a part icular blood group at a par1icular 
t ime.  Th main object i \ e of our present tud) is to as ess the d istribution of blood 
group In I A in area. that Vv i ll help  in deteml in ing the stock of blood and b lood 
component needed, so that there wi l l  be no shortages or expIry I ssues of these 
product . Addit iona l ly. this tudy wi l l  help in saving the t ime and the money needed 
in col l ect ing. proces ing. and testing of the e products .  Results from this study can 
help  in mapping a nat ional status for future references. Moreo er. i t  w i l l  help in 
preparing databa e for the blood bank and also create awareness as who is exposed to 
\\ hich of the di eases . Besides this .  the kno",rledge of the blood groups and genotypes 
in regards to the health of an indiv idual is important and useful for medical 
d iagnosis .  genetic informat ion. genetic coun eJ ing. forensic medicine needs. and also 
for the general \\ e l l being of indiv iduals .  
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C h a pter 2: M e t h od 
2.1 tudy a p p roval  
Thi tud) "\\ a appro\·ed b) the AI In tfedical Di  tr ict H uman Re earch 
� thical committee \\ hich is  an accredi ted organizat ion of  Federal Wid 
( FW ) and compl iant \\ ith ICH/GCP tandard . 
2.2 Blood am ples col lection 
ssurance 
Random b lood ampl s Vv ere selected [rom local ( UAE national ) male and 
female ( -+-+0 male. and 60 female ) donor from d i fferent age groups ( 1 7  - 58 years 
o ld)  \Vho donat d b lood at Al  i n  R gional B lood Bank ( AA R B B ). The election of 
these amples depend in  the report generated from eProgessa the laboratory 
informat ion sy tem used in AARBB.  Thi report howed the gender, age. the place 
of b i rth and other i n format ion .  1 1  i nd ividual invest igated were from Al Ain area and 
the consent fom) of a l l  donor as obtained before donat ion.  
2.3 Serology typing 
2.3. 1 ABO phenoty p i n g  
Forward and reverse A B O  groupl l1g was perfolmed by conventional tube 
method and by gel technology. For forward ABO grouping, commercia l ly  avai lable 
monoc lonal b lood group anti era i . e  Anti-A, Anti -B,  and Anti-AB were used whi le 
for reverse grouping. the A 1 and B cel l s  prepared in  5% su pension were used. All  
these reagents \\;ere purchased from Bio Rad. Gel technology also was used by 
perfoml i ng the test i n  the ABO forward and reverse grouping using Bio Rad gel card 
technology. 
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2.3.2 R h D  typ ing  
Rh D  typing \"°a done by  tube method as  wel l  as  by  gel method usmg 
monoc lonal poly  c lonal Ant i -D ( Rho & Rhd and by u mg Bio Rad gel card 
re p ct i\  e ly . 
2.3.3 Rh phenotyp ing  
For  d tect ion of  tatu of re t of  the major ant igen of Rh system apmi from 
ntigen D i .e nt igen C, c. E & e speci fic monoclonal anti sera ( Bio Rad ) were used 
and te t was performed by tube method as wel l  a by gel method. False posit ive and 
fal negat i ve r suI ts  \-vere strict ly  avoided by taki ng q ual i ty contro l  measures at each 
tep. 
2.3.3. 1 Determination of most p robable Rh genotypes 
By using the five a\'ai lable antisera ei ther by tube method or by gel cards for the 
five major ant igens of Rh group, phenotype of the donor is reflected in the results .  
Determi nation of  exact genotype i s  not possible wi thout testing parents and other 
fami l y  member or by RNA test ing.  For thi reason most probable genotype is 
determi ned from gene frequency estimate depending in the phenotype resul ts .  
Follow i ng steps a re ta ken to deter m i n e  the possi ble genoty pes from the i n d ivid ual 's  
pbenotype: 
1 .  I f  D i s  po i t ive.  the number of possible genotypes i s  one less than the number of 
posi t ive reactions.  
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2 .  I f  D i negat i \  e .  the number of po  ib le  genot� pe i s  two Ie than the number of 
po it i \ e reaction . 
3 .  One haplotype i inheri ted from each parent ( for example, D e/dce 1 S  one 
genotype ha\ ing both the DCe and the dce haplolypes)  . 
.t. Mo t p robable genoty pe from the po i b le genotype \\ a calcu lated a 
how n i n  the  fol lowing  example :  
I f  donor's phenoty pe i s  0+. C+, E- ,  C+. e+, then we have 4 posit ive reactions and the 
D i p it ive.  \\ e should ha\'e 3 possible genotypes. When D i posit i \ 'e. we don't 
kno\\ i f  the donor i nherited 0 from 1 parent or both parent . a we i mmediately ha\'e 
:2 po i b i l it ie : 
a .  One genot'pe \\- here 0 w as inherited from both parents:  0 ??/D?? 
b .  One genotype where 0 wa i nheri ted from only 1 parent : D??/d?? 
ext look at al le le C and c. i f  only one is present, it must be i n  both haplotypes. I f  
both are pre ent assign one a l le le  t o  one haplotype. and the other a l le le to the 
remain i ng haplotype. I n  th i  example, 'W e have both C and c present, so C wi l l  assign 
to one haplot) pe and c to the other. ( DC?/Dc? Or DC?/dc?) .  Repeat thi process to E 
and e .  and because on ly  e i s  present, i t  must be in  both haplotypes ( DCe/Dce =R, Ro . 
or DCe/dce = R , r ) .  F i  her & Race Rh nomenc lature wa used i n  this study. ( see 
table 4 ) .  
2.4 Molecu lar  ana ly i for the determinat ion of R h D  negative var iant  
2 .4. 1 D A Extraction 
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I I  the D extracted proce \v r perfoll11ed according to manufacturer's 
protoco\ '  The fi r t tep of  analyzing the genomic D A i to i olate D from ti ssue 
or ce l l '  u ing a ombination of physical and chemical methods. Many d ifferent 
platf01l11 and technologi s are a\'a i lable .  I n  the current study the genomic D A of 
r RhD negat i \  e sample were extracted from 200 11 1 a l iq uot of EDTA whole b lood 
ei ther on the Maxwel l  R 1 6  instrument to perform automated i solat ion of genomic 
D A from whole blood u ing Max\\ el l  R 1 6  D N A  puri ficat ion k i t  Cat# A 1 0 1 0  
according to manufacturer's instruction . This i nstrument purifies samples using 
paramagnetic part ic les ( PM P  ),  \ hich pro ide a mobi l e  sol id phase that opt imizes 
capture. washing and e l ution of the genomi c  D A. The magnet ic part ic le  handlers 
transport the PMPs through puri fication reagents in the prefi l led caliridge and mix 
during proce s ing ,  This i n  trument can process up to 1 6  samples i n  30-40 minutes. 
The other method used to extract the genomic DNA from whole blood was the 
manual procedure using Q I Aamp D A Min i  and B lood M i n i  Ki t .  The basic principle 
of thi kit can be described in four stages:  the fi rst stage i s  to lyse the red blood cel l s  
w i t h  buffer AL.  physical agitation i n  the presence of proteinase K .  buffer AL 
contains  sod i um dodecyl  su lfate ( SD S )  detergent that d i srupt cel l membrane and 
d issociates protei n  D A complex. Proteinase K solution, meanwhi le. degrades 
proteins inc lud i ng DNA scaffo ld ing proteins and other protei n  debri s .  The second 
stage is to isolate D A from the cel l  by adding Ethanol ( 96- 1 00%).  Ethanol i s  used 
to precipitate D A out of flu id  uspension. Therefore, it increases D A affIni ty to 
b ind to the Q I Aamp Min i  spin colunm for fUliher e lut ion of D A through the spin 
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column.  fhe th ird tage. i D '  puri fication. The puri fi cation tep u e \\ a h buffer 
( W I  and A \\'2) .  Each of the buffer ha a d i fferent ethanol concentrat ion.  W I 
being the more concentrated buffer fol lo\\ ed b) W2.  This ensure the D A remain 
hound to the pin column.  The buffer act to di solve and remm,e cel l u lar debris and 
c ntam inant that are not bound to the pin col umn matrix .  The re u l t  of thi stage i 
to lea\ e c lean and puri fied 0 bound to the col umn. The final tage of the D 
extraction i l ut ion .  f n  this tep buff r E is u ed. The buffer AE \vi l l  increase the 
) ie ld b) up to I So 0 and suitable for long term storage of DNA since ON stored in  
\\ ater i ubj ect to ac id h) drol)  s is .  
protocol typica l l )  y ie lds 6 Ilg of D 
200 II I ample of  \\"hole blood u ing both 
( 30ng/�d ) \vith an A 260 I A 280 rat io of 1 . 7- 1 .9 .  
2A.2 Quant itative meas u rement  of extracted genomic  DNA 
DK q uanti fication is  crit ical for molecular analysis .  There are several methods 
used to e tab l i sh the concentrat ion of D A i n  sol ut ion.  The most common method of 
D quantification i spectrophotometric quant i ficat ion .  I n  th is  study DNA was 
q uant i fied by u ing ano Drop 2000 V-Vis  spectrophotometer. This instrument 
mea ures the concentration and purit) of the extracted D A using on ly 1 II I and the 
re u l t  obtained i n  less than 1 5  seconds from ample pipett ing to \\fi p ing the pedestal 
c lean.  Eac h  sample was run 3 t imes to make sure of the qual i t  of the results 
obtained and the concentration average was calculated. 
2A.3 Qua l itat ive determ inat ion of extracted DNA 
The extracted genomic DNA samples were analyzed by e lectrophoresi s  on a 1 % 
agarose gel ( 1 . Sg  agarose, 1 50ml I X  TBE and 8 11 1  EtBr. The vol tage= 1 00) .  Then the 
gel was analyzed under the UV l ight and the graph were taken. Electrophoret ic 
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eparat ion i b a  ed n the principle that a charged part ic le wi l l  migrate toward one 
of the ele tr de \\ hen placed in an el ctrical fie ld .  Th p ed and d i rection a 
charged part ic le  mm e can be determi ned b) it net charge, size. shape and 
molecular weight a wel l a external factors uch a the composit ion of the buffer. 
the \ oltage u ed among ther \ ariable . 
2AA A m p l ification p roce u ing T I OOtm Thermal  Cycler ( B io Rad ) 
The PCR al low electi ve ampl i fication of a determined port ion of D A in 
\ i tro .  The t chnique \\ as made po sible b) the di cover)' of  Taq polymerase. ", hich 
i' tabl at h igh temperatures. In this tud) PCR was performed using T 1 OOlm 
Thermal Cycler ( B io Rad ) to ampl i fy and detection of the RH gene of the RhD 
n gat ive ample , \\ hich i based on the diagno t ic ampl i fication of  a DNA sequence 
pre ent in the Rh-po i t ive indiv idual and absent i n  Rh-negat ive. 
2AA. l Primer  selection 
Because D and CcEe genes are h igh ly  homologous. i t  i s  possible to de ign primers 
that anneal to a region of the D gene and also to a region of the CcEe gene, see figure 
4 .  I n  that \\"ay. a l l  D A samples pro\'ide a template for ampl i fication. Primer D 1 for 
a equence l ocated in  exon 4 ( posit ion nt 52 1 -540) ,  and primer D2 for a sequence 
l ocated in exon 5 ( posit ion nt 670-65 1 ). were used to d ist i nguish the RHCE and RHD 
genes as shown i n  table 6 which were selected accord ing to  S imsek e t  al . The bands 
resul t i ng from the PCR ampl i fication are shown in figure 6. 
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P ri m e r  Detect ion 
of 
0 1  
exon 4 R H D  and 
02 I 1t  670-65 1 R H C E  
eAon 5 
uro fi u  MWG-Operon-Europe (AI  Mazroui  medical and 
chemical uppl ier). 









0 1  02 
1 200 bp 
E4 E5 
o 0 





F ig u re 6: Pri mers D I and D_ . Boxes i n d icate exons.  The annea l i ng of D l  and D2 
pri mers to complementary D and C c Ee D A region i how n .  D I and D2 b ind  to 
exon 4 and exon 5, respect ive ly, in D and CcEe genes.  The band res u l t i ng from the 
PCR ampl i fication are repre ented. 
2.4.4.2 Selection of the a p p ropriate genomic DNA vo lume 
Accord i ng to  the results obtained from the gel electrophoresis ( genomic D A)  
the appropriate o l ume for each samples (45 samples) were determined to prepare 
the fi nal PCR reaction of 25 � I to be run .  
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2 .4  .... . 3 Preparation of PCR reaction 
Th po it i \ c  R H D  'ampl \\ hich used a a control sample wa carried out 
\\ i th 2 II I  genomic D , 1 2 . "  II I  T Q P R Ma ter Mi  ' .  1 .5 II I of each forward and 
rc\ crse primer ( l Op 1 )  and 7 .5  III D free water in  a 25  II I reaction \ o lume as 
'ho\\ n i n  table7.  The other peR reacti ns \.\ ere prepared \.\ ith d i fferent genomic 




PC R M aster M ix 
H 2O DNA free w ater 
Tota l vo lume 
Volume ,... 1 
2 
l . 5 
1 . 5 
1 2 . 5  
7 .5  
2 5  
Table 7 :  Fi rst PCR reaction for Q C  amples and the other remain i ng D A san1ples 
Vol u me ,.t 1 
9 
D A 
1 . 5 
F D I  
1 . 5 
RD2 
1 :2 . � 
peR M a  ter M i x  
0.5 
H2O D N A  free water 
25 
Total , o l u me 
Table  8: econd PC R react ion for samples # 1 7,26, & 29 
DNA 
F D I  
RD2 
pe R M aster M ix 
H2O DNA free water 
Total vo l u m e  
Vo l u m e  1-11 
5 
l . 5 
1 . 5 
1 2 . 5  
4 .5  
2S 
Table 9 :  Third P C R  reaction for samples # 28 & 30 





F D I  
1 . 5 
RD2 
1 2 . 5  
P C R  M aster M i x  
8 . 5  
H 2 0  D N A  free water 
? �  _J  
Tota l vo lume 
Tab le  1 0 :  Fourth PC R reaction for samples # 1 1  & 1 2  
2AAA Thermal  cycle p a rameters for T I OOtm Thermal  Cycler ( B io Rad )  
1 1  P C R  reaction consi ted of hot-sta11 cyc le at 95°C for 5 minutes, fol lowed 
by 3 5  cycles of PCR in T I OOIn] Thermal Cyc ler. Each cyc le should be done at 
d ifferent condi tions  inc luding 95°C for 45 seconds, 64°C for 1 m inute and 72°C for 
1 .5 m inutes. fol lowed by final extension at 72°C for 5 m inutes as hown i n  table 1 1 . 
Cycle Stage Temp.  D u ration Description 
Hot-start 95°C 5 m inutes Reconfiguration of enzyme 
once 
Denaturation 95°C 45 seconds dsD A spl i t  to ssD A 
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Annea l ing 64°C 1 minute primer anneal to b inding site 
Extension 72°C 1 : 30minutes primer extend by enzyme 
Post- 72°C 5 m inutes A l l  strands extend to i nc lude 
once 
extension extra adeni ne base 
Hold 4°C Temp. decrease to donate end 
once 
of proces 
Table 11 : pe R them1al cyc les parameters 
2A.S Oet ct ion of a m p l ified PC R product 
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r he P R product \\ ere analy zed b) electroph re i on 1 .20 0 agaro e g 1 .  
Tracklt  T m  1 Kb pIu 0 
1 inear double- tranded 0 
ladder Cat . o. 1 0488-085 \\ a u ed a a marker to ize 
fragment from 1 00bp- 1 2kb.  Then the gel \\ a anal) z d 
under the e l i ght and the graph were tak n .  
2A.6 PC R p rod u ct eq uenc ing  
The unpuri fied PCR products v,;ere packed and en t  to  Macrogen Korea that 
en ed over 1 0  year In equenc lng field using cutt ing edge technology and 
del i ,  ering fa t re l iable re u l t  . The) us h igh throughput App l ied Biosystems 
3 73 0  "L equencer . The Appl ied Bio y tems 3 730XL 0 A analyzer are automated. 
high throughput cap i l l ary e lectrophoresis systems used for analyzing fluorescently 
labeled D T fragments. ( for more deta i l  refer to Appl ied B iosystems 3 7 3 0/3 730XL 
D A analyzer equencing chemi try guide) .  
2..4.6. 1 R u n  a m ple oHn ie\\ 
Bdow is a diagram o r  the 0 A Anal) zer run c)- c 1e .  
r; I Autosampler 
brings waste 




Figu re 7 :  D 
2 ..4.6.2 Sam ple Packing  Req u i rement : 
Capillary array IS 
filled with polymer 
�utosampler 
bnngs buffer 
reservOIr to caPillary 
array 
ana I) zer run C) c Ie  
;� Autosampler 
posItions plates to 
CaPillary array 
-I- Electrokinet ic 
Injection 
3 1  
The below table 0 . 1 2  show sample packing requ irements to be shipped to 
Macrogen Korea. 
Template Sample requ irements P6mer requirements 
Unpur ified 1 OOng/�1  M in imum 1 Opmole/�Ll =60ng/�1  
peR products volume of 30 �l M inimum vol ume of 20�1 
Table 1 2 : sample packing requ irements 
204.7 equencing re u lt ana lyze 
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I he , CBI  databa e wa u ed to  obtain the tv" nuc leotide equences of exon � 
to exon - of  both RI- lCE ( acce ion 1 0 : 6006) and R H O  ( acce ion 10: 6007)  gene. 
The'e btai ned equence \" ere compared to th fol lo\\ ing acces ion numbers: int ron 
-+ RH E: Y 1 0604, and i l1 1ron 4 R I I O :  Y I 0605 to recogmze the ize d i fferences 
bet\\ een intron � of R H O  and R I- ICE.  
The equence of the te ted samples \"ere a l igned to the \yi l d  type sequences of 
RHO and RHCE u ing M C LE and T-coffee programs .  nd the results \\ ere 
analyzed. 
2 04.8 Statistical ana lyze : 
Frequenc) of  BO and the Rh phenotype and most probable genotypes for a l l  
studied group. and RH O-negat ive variants screen ing among RH D-negat ive donors 
were a sessed us ing dependent sample T-te t where P< 0.05 I ndicates a signi ficant 
d i fference using PS Program. 
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C h a pter  3 :  R e  u l t  
3 . 1 Serological analysi  
Random Blood 'amples \\ ere elected from E local male and female (-l-l-O 
male & 60 females) donor from di fferent age group ( 1 7-58 year o ld )  \\ ho 
donated b lood at 1 Ain Regional B lood Bank ( ARBB) .  The e samples ( total of 
- 00 ample ) \\ ere tested for ABO forward and reyerse grouping using convent ional 
tub method and Diamed Gel Teclmolog) . Th Rh antigens ( D. C. c. E & e) were 
t) ped u ing al 0 the arne methods. And b) analyzi ng the results obtained the 
frequencie of ABO and Rh phenotypes and most probable genotypes were 
determi ned . 
3. 1 . 1  A BO p henotype frequency 
The trik ing feature of the ABO sy tem in Al  Ain population studied here ( total 
tudied populat ion)  was the predomi nance of the phenotype 0 ( 5 6%) ,  fol lowed by A 
(26 .20 0) ,  B ( 1 4 .20 0) .  and AB ( 3 .6%) as shown i n  table 1 3  & fi gure 8 .  The frequency 
of ABO b lood groups in a total of 500 male and female donor population was 
compared. The percentage of A. B. A B  and 0 blood groups among studied male 
ubjects were 26 .5 ,  1 -1- . 5 .  3 . 8 .  and 5 5% respectively ( table 1 3  & F igure 9). For the 
females. the percentages of ABO blood groups were 25 .  1 1 .6,  1 .6, and 6 1 .6% for A. 
B,  A B ,  and 0 groups respectively ( table 1 3  & figure 1 0) .  There was no significant 




Blood G roup  �Iall'  Female  I Total I 
1\umbcr ° 0 I �umber ° 0 0:umber 0 0 
A I 1 1 7 26.5 1 5  I , - 1 32 26.4 I - ) 
B 6-t 1 4.5 7 1 1 . 6 7 1  I -t .2 
A B  1 7  I 3 . 8 1 1 .6 1 8  3 .6 
0 2-t2 :' :'  37  6 1 .6 279 56 
Table 13: Distribution of di fferent ABO blood grou amonu male. fI male '- P b 
and total tudied population. 
Oi tr ibut ion of ABO in the Total  Stud ied Pop u lation 
Figu re 8 :  Distribution of ABO i n  the total studied populat ion 
Distr ibution Of A BO betw een M a le S u bjects 
A 
27% 
Figu re 9 :  Distribution of ABO between male subjects 
Di tr ibution of A BO Betw een Female u bject 
AS 
1 0 '0 
Figu re 10: Distri bution of ABO between female subjects 
3. 1 .2 Distr ibution of R h D  ( posit ive & negative)  phenotypes 
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The percentage of  Rh po i t i  e and R h  negat ive blood group among studied 
male ubjects " ere 9 1 . 1  and 8 ,9  % respecti el  as shown i n  table  1 4  & figure 1 1. For 
studied female. the percentage of Rh b lood groups were 85 and 1 5% for Rh positive 
and Rh negative groups respect ively ( table 1 4  & fi gure 1 1 ) . There was no signi ficant 
d i fference in di  tr ibut ion of Rl1 blood groups between male and female subjects. The 
d istr ibution of Rh posi t ive and Rh negative groups among total studied population 
\vere 90A and 9 .6% re pectively as shown in table 1 4  & figure 1 1 . 
Blood G ro u p  Male Female Total 
N umber �'o N umber % N umber o� 
Rh-positive 40 1 9 1 . 1  5 1  85  4-'  )- 90.4 
Rh-n egat iYe 39  8 .9 9 1 5  48 9 .6 
Table 1 4 :  Distribution of different Rh phenotypes among male, female. 
and total studied populat ion 
Di tr ibut ion of Rh D phenotype among Male Female, and 
total tud ied popu lation 









9 1 . 1  
85  
90A 
Male Female Total 
36 
Figu re 1 1 :  Oi tribution of different Rh phenotypes among male. female. and total 
studi d population 
3. 1 .3 Distrib ut ion of Rh ant igens 
Regarding Rh ant igen . table 1 5  shov. the d istribution of Rhesus antigens in the 
total population studied which are as fol lo'vvs :  0= 90.4%. C= 76.2%. E= 27 .2%. c= 
7 1 .60 0 and e= 97 .8%.  These antigen were compared to each according to its 
react iv i ty with each ant i sera a shown i n  figure 1 2 . The genotype frequency wa 
ba ed on the 1110 t probable genotype for a given phenotype. For that, the d istribution 
of  1110 t probable genot) pes as fol lows: RJ r = 29.8%. RJ RJ = 2 8 .4%, RJ R2 = 1 6.8%. 
















Reaction \\< it h  A n t i- phenot) pic Mo t P robable 
Desi� n a t ion  Genot) pe 




I RhO-pos D-pos RhO-pos D-pos 
Pos rh' - pos C-pos rh' - pos C-pos 
Pos rh" -pos E-pos rh" -pos E-pos 
Pos hr'-pos c-pos hr'-pos c-pos 
I Pos hr"-pos e-pos hr"-pos e-pos 
Neg Neg Pos Pos rh rh ccddee IT cde cde 
Pos j'ieg Pos Pos rh' rh Ccdee r'r Cde/cde 
Neg Pos Pos Pos rh" rh ccd Ee r!lr cdE, cde 
Pos Pos Pos Pos rh' rh" CcdEe rlr" Cde cdE 
Pos Neg lJeg Pos rh' rh' CCdee r'r' Cde Cde 
Neg Neg Pos Pos Rhorh ccDee Ro r cDe cde 
Pos Neg Pos Pos Rh l rh CcDee R l  I' C De cde 
Neg Pos Pos Pos Rh� rh ccDEe R2 r cDE cde 
Pos Neg Neg Pos Rh l R h l  CC Dee R l  R l C De/C De 
Neg Pos Pos Neg Rh2 Rh1 ccDEE R2 R] cDElcDE 
Pos Pos Pos Pos R h l  Rh�  Cc DEe Rl R] C De'cDE 
Pos Pos Neg Pos R hz R h l  CCDEe Rz R I C D E C De 
Pos Pos Pos Neg R J1; Rh] CcDEE Rz R] C D EcDE 
Ta ble 1 5 : Di tr ibution of Rh phenotypes and most probable genotypes 
Distribut ion of Rh p henoty pes 
1 '20 
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3.2 Compari on of the di tr ibut ion of d i fferen t  blood group ben een the 
p re ent a n d  other tud ie  
Distribution of the B and Rh blood group obtained i n  the present tudy were 
igni ficant i)  d i fferent with tho e of e\ eral other studies ( P< 0.05 to P< 0.00 1 for 
ABO group and P< 0.05 to P< 0.0 1 for Rh groups ) as sbov- n i n  table 1 6, 1 7 . 1 8  and 
figure 1 3 . 
Pop u lat ion 
A. ia  
A l  A i n  (UAE)  
Kalba ( L A E) 
. audi A rabia  
Kuwait  
Kurd s  ( I raq)  
I n d ia 
I nd ia  
Pakistan 
E u rope 
B rita i n  




N a i robi  
Sudan 
G u inea 
N iger ia  
Reference 
present tud) 
Taha, J . lT• ( 20 1 2) 
Bashwa.ri . L . .et al ( 200 1 ) 
AI-Bustan. S .. et a 1 .  ( 2002) 
Jan: M . S .  ( 20 1 0) 
Agra\\ al .  A . .  et a l .  (20 1 4 ) 
Khattak. I . D  . .  et a 1 .  (2008) 
Khattak. LD . .  et a l .  (200 8 )  
Khattak. t . D  . . e t  a l .  (2008)  
Tauszik .  T. ( 1 995)  
Akba . F . .  e t  a l .  ( 2003 ) 
Borghcse. B . .  et a l . (20 1 4 )  
Lyko 1 . .  et a l .  (1 992) 
Khal iL  LA . .  et a l .  ( 1 98 8 )  
Loua. A . .  e t  a l .  (2007) 
Falusi ,  A .G . .  et a l .  (:2000) 
A %  B% AB% 0% 
2604 1 4 .2 3 .6 56 
24 22 .8  4 . 7  4 8 .4 
26 1 8  4 5 1  
1 6  1 4 2.6 66.7 
32 .47 23 .84  6.53 37 . 1 6  
22 .88  32 .26 7 .74 37 . 1 2  
1 8 . 8 32 .5  9 .9 3 8 . 7  
27 .9 32 04 1 0 . 5 29. 1 
4 1 . 7 8 .6 3 46 .7  
27.6 1 2 . 1 8  4 .2  5 5 .9 
1 2 .2  1 1 . 1  0. 8 73 .9  
47 .5  1 0.3  3 3 8 .9 
1 5 . 8  1 2 .6 2 .39  69 
1 8 . 1 4  1 2 .3  2 .68 66.8 
?? -- � . )  1 3 . 8  4 .72 48 .8 
24,4 1 3 . 8  2 . 75 48 .9 
Table 1 6: Comparison of distribution of dIfferent ABO blood groups 1 11 the present 
study with those of other studies:  
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Pop u lation Reference I Rh +(% )  I Rh -( % )  � 
Asia 
Al Ain \CAl�) present stud� 90.4 9.6 
Kalba ( l iA r )  Taha. J . Y. ( 20 1 2 ) 9 1 . 1  8 .9 
audi rubia Bash\\ ari. L . .�t al  ( 200 1 ) 92 8 
Jordan Abou-JabaL . . ,  et a l .  ( 2003 ) 87 .2  1 2 .8 
Kurds ( Iraq) .raff. !\1 . ' . ( 20 1 0 ) 9 1 . 7 8 .27  
I nd ia  Agrawal .  . .  e t  a l .  (20 1 4 )  94 .6 1 5 . 39  
I nd ia  Khattah.. 1 .0  . . et  a l .  ( 2008 )  94.45 5 . 5  
Pak i tan Khan. M . .  et a1 . ( 2009) 89 .5  1 0.5  
E u rope 
Britain Khattak. LO . . et al .  ( 2008 )  8 '"  -) 1 7  
Germany Akbas. F .. et al . ( 2003 ) 95 5 
French Borghese. Boo et al .  ( 20 1 4 ) 76.9 2 3 . 1 
Africa 
Tigeria Falusi.  A .Go o  et al .  ( 2000 ) 94 . 3  5 . 7  
�orth  America 
Khattak. 1 . D  . .  et a l .  ( 2008)  85 1 5  
Table 1 7 : Comparison of d istribution of  RhD phenotypes in  the present 
study with those of other studies 
I 
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Popu lat ion Reference. D% C% cl% E% e°lt) 
E) pr�"ent tud� 904 76.2 7 1 .6 17.'2 97 .8 
E )  Taha, ]Y ('20 1 2  9 1  1 73 .2  7 1  0 '2 J .O 97.3 
Abou-Jabal. A. et a!.  ( 2003 ) 87.1 67 .9 80.3 30.2 96 .6 
lIa�"an. f . \ 1 . . et al (20 1 3 )  93 . 1 1 1 .9 99.8 1 3 .8 99.8 
\\ cst A fr ica 
. 1r<lIlS) Bogul, L . ,  et a l  91.9 1 1 .9 99.8 1 3 .8 99.8 
('20 1 4 )  
Table 1 8 : Compari o n  o f  d i  tribution o f  di fferent R h  ant igen i n  the pres nt 
stud; � i th tho e of other studies 
Com parison of the d istr ibut ion of d ifferent Rh antigen 
betw een cu rrent  tudy w ith tho e of other stud ies 
1 20 
A J  A i n  ( E)  1 00 
• KaJba ( AE)  
80  
Jurdan 
aud i Arabia 60 
• 'W est A frica 40 
20 
0 
00 0 CO O CO 0 EO o  eO ° 
Figu re 1 3 :  Comparison of d istribution of d i fferent Rh antigens i n  the present study 
with those of other studies 
3.3 Com pa rison of d istribut ion of Rh phenoty pe and most probable genotypes 
between the pre ent and other tud ies 
The d istr ibution of the most probable genotypes \ as obtained and found as 
fol lows : R I  r = 29 .8%, R I  R I  = 28 .4%. R I  R2 = 1 6 .8%, rr= 8 .4%, R2 r= 8 .2%. Ro 
r=5%. R2 R2 =2 .2%, and r'r = 1 .2% as shown in table 1 9  that can be compared with 
other studie . 
phenot�  pic \10 t P roba ble 
'---Des ign a t ion  Genot \ pe I I 
I 
\\ iener F isher- W iener  F i  her-
Race Race 
I 
RhO-pos D�pos RhO-pos D-pos 
rh' - pos C-pos rh' - pos C-pos 
rh" -pos E-pos rh" -pos E-pos 
hr'-pos c-pos hr'-pos c-pos 
hr"-pos e-pos hr"-pos e�pos 
rh rh ccddee IT cde/cde 
rh' rh Ccdee r'r Cde/cde 
rh" rh ccdEe rllr cdE cde 
rh' rh" CcdEe rlr!! Cde cdE 
rh' rh' CCdee r'r' Cde Cde 
Rhorh ccDee Ro I' c De cde 
R Il l rh Cc Dee R I I' CDe/cde 
Rh� rh ccDEe R2 r cDE 'cde 
R h l  RIl l  CCDee R I R I C De, CDe 
RIl, RIl, ccDEE R2 R2 cDE cDE 
Rh l Rh� CcDEe R I R2 CDe1cDE 
Rhl RJ1 1  CCDEe Rz R I  C D E/C De 
Rhz Rh2 CcDEE Rz R2 C D E/cDE 
% % 
% Kalba Sa u d i  
P re en  
A E  A ra bia 
t fud)'  
Taha. 
Hassan. 
J . Y .  F . M  . . et 
(20 1 2 )  
a l .  
( 20 1 3 ) 
90A 9 1 . 1  93 . 1  
76.2 73 . 2 62.3 
2 7.2 2 1 .0 42 .7  
7 1 .6 7 1 .0 4 1 . 7 
97 .8  97 .3  9 1 .0 
8.4 7 .3  . . . . . 
1 .2 1 .2 . . . . . 
0 . . . . . .  . . . . .  
0 0 . 1 . . . . .  
0 0 .6 1 . 7 
5 1 0 .9 30.8 
29.8  30 .9  9 . 5  
8 . 2  6 .7  . . . . .  
2 8 . 4  2 8 . 1 8 . 3  
2 .2 1 . 8 . . . . . 
1 6.8  1 1 . 5 3 0 . 8  
0 . . . .  1 3 . 7 





Bogu i.  
L. .  et al .  
(20 1 4 ) 
92.93 
2 1 .97 
1 3 . 82 
99.85 
99 .85  
5 .6 
1 .3 
. . . .  
. . . .  
. . . .  
60.5 
1 8 . 5  
1 1 . 8  
. . . .  
. . . . .  
1 . 8 
. . . . . 
. . . . . 
4 1  
% 
J u rdan 
I Abou-
Jabal. 
A . . et al .  
(2003 ) 








0 .5  
0 .5  
. . . .  
� � � J j . J  
1 2 .2 
1 8 .9 
3 .2 
1 3 .3 
0 .3  
0.2 
Table 1 9 : Comparison of d i stribution of Rh phenotype and most probable 
genotypes between the present study and those of other stud ies 
3A �l olecu lar  ana l} 
3A. l Molecu lar  ana ly i of the extracted genomic D A 
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total of -+8 sampl ' ut of 500 found to b RhD negat i \'e that corre pond to 
9.6 �o for Rh O  negat i \ e ph n type. The cde phenotype wa counted for -+0 ample 
( 8 ,-+0'0) and e phenot) pe D und in  5 ample only ( 1 . 20 0 ) .  I n  our tudy Th D A of 
45 ample \v re e, tracted ( 3  amples \\ere 10  t ) ,  and the qual ity of the extracted 
D \va as e sed ei ther b) anodrop or by gel e lectrophoresis .  The captured gel 
picture are ho\\ n in figure 1 -+ . 
Figure 1 � :  Determ i nation of the q u a l ity of extracted D A of tbe te ted samp les. 
3.4.2 Detect ion of R H O  gene b) pe R Product ana ly i 
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For d tect ing the pre ence or ab ence of the R H O  gene. the PCR ampli fication 
for intron 4 f the RI I D  and RH E g ne \\ a per[om1 d by primers 0 1 '02 a 
ho\\ n i n  figure 6. I n  that \\ a) . a l l  0 ample provide a template [or 
ampl i iicat ion.  D i fferent ann al ing temperature ( � 8 .  6 1 . and 64°C )  were u ed. and the 
be t \\ as 64" C .  Rh-po i t ive P R products ( qual i t) control ample ) shov;ed two­
band of di !Terent s izes that COlTe pond to 600bp ( 0  gene) and 1 200bp (CcEe gene), 
vv h i lc Rh-negat ive sample hov, ed a i ngle band corr sponding to the fragment of 
the CcEe gene a ho\\ n in  figure 1 5 . 
1 .2Kb � 
O.6Kb � 
M (+)1 (- )1 
Figu re 1 5 :  Qual ity Control PCR products; (+) : i nd icate RhO posit i  e, ( - )  
i nd icate R h  negat i e 
I ntron 4 of the RHCE gene wa ampl ified in  a l l  the 45 tested samples (RhD-
negat ive ) .  These samples gave the 1 200 bp bands with d i fferent band i ntensi ty as 
ho\\ n in figure 1 6. 
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Figu re 1 6 : PCR product gel electrophoresis resul t  of the tested Rh 
negat ive samples 
304.3 Sequenc ing of I n tron .t of the R H D  and RHCE as PCR products 
The R H C E  and RHD gene are compo ed of 1 0  exons. A delet ion of 600 bp i n  
i ntron 4 of  the RH D  gene was ident i fied. H uang showed a l l  sequence of i ntron 4 i n  
the R H D  gene. and indicated the existence of the human Alu repeat i n  intron 4 of 
RHCE gene ( Huang. C. ( 1 996) ) .  Avent, ND et a1. demonstrated the All! element 
i m i l ar to H ung's report in addit ion to a l l  sequences of i ntron 4 in both RHD and 
R H C E  genes ( Avent. . D  .. et a!. ( 1 997) ) .  To ident i fy i ntron -+ in  both the RHD and 
RHCE genes. we carried out PCR ampl i ficat ion with Primers D I /D2 . The nucl otide 
equences of i ntron 4 of RHCE and RHD genes are shown in figure 1 7 . I t  was 
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confirmed that the di fference in  Ize between intron fragment of RHD and RHCE 
gene deri \ e fr m a deletion. and that the non-deleted equence of RHD gene i 
identical to the RHCE gene xcept for three nucleotid ( Huang, C. ( 1 996) & vent, 
N . D  .. et a l .  ( 1 997) ) .  The s quence resul t  \\ ere compared \\ ith the wi ld type 
equence of the exon 4 through e on 5 of R H D  and RHCE gene. 
Run � t"lJr  I xm. � 
1<11/) g(l/, L \O;\� 
gta a99acaa99tqqg9tqa9t9g tct � ae �99gc t9aqe agaa l 9 9c Leaqaaaa9ge l c l g9c t q 
q taagqacaa99 9999 9agtg9t ct 99t 8ct � q99c 96geaga6t9gc t-agaaaaggctct99c t 9  10 
aaaaaatctccctcc�� aeca4dl tcccct999 9te 9aa9ccc t tcca tcatga t tc�tet t  98 
adaaaatctccctcc�' 6cc a� tcccc t999t9tct96agccc tcc8tca tga t tc� tc t t t qa 110 
.ctttla9qq8cctctcttcattaatatcca 9 t 0 9 t 9  tgctaaa tcatacctttq8a taagc c t 1 1 0  
g t n9 t g t t tgctaaat tcatacctt gaa taa9c c t tc - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
ctnqannggdqaq4ctcatta tqtgtqaqtltcaataaglttalccaatccctltqttttcaactqaaaq 2 80 
HO 




4caaacaaatcagctgggcatggtggtgcacgcctgtaatcccagctact tgggaggctgaggcaggag 100 
atcttttgaatccaggtggtq96g9ttgcagtgagccaagategcgcc6ctgC8ctcc8gcctgggcaac 7 7 0  
agagcaagagtccatctcaa t taaaaaggaaaaaaaattaaaataagcatttgaccat acagagcaggt 840 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -acagagcaggt 
:caggeggc t ggggtatg agatt ceaccct t t ggcct t tg t t tc c  t g tc 9 aaaatgtggttag 
:caggaggc tgggg atgcagatt tca8Ccc C 9gcc t t t g  ttc t gte gt a a a a t gt ggttag 910 
c�ggt ateagc gaqagctcggagg9ga98cg gae tcce a t e t a a  t c  aagtgacaaggc gaga 
c �gg a cage gagagct gqaggggagacg gae tccccatctaac c aaqtgacaaggc gaga 980 
e �e t cea gecc t agga teleB eeaaaaecce eg3ggcteagacct tgg8gCJggag gtga tc 9 10SO ctctccagecetaggattCtcatccaaaaccectegaggctcogQect t t ggagcagg aqtgtgattctg 
gecaaccaccctctctggcccccag 1--0",.,.,.,.,"';"'_,.,..,.. __ 
gccaaccac=c ctct ggcccccag L......""";';""'-__ 
Figu re 1 7: The nucleotide sequences of i ntron 4 of the RHCE ( upper) and 
RHD (/Oll 'er) genes. The RHCE and RHD genes consist of 1 ,075 and 426 
nuc leotides, respectively.  The black letters demon trate the common region 
of the RHCE and RHD genes. The white letters show the spec ific region of 
the RHCE gene. The l etters surrounded with an oblong frame i ndicate the 
nuc leotide subst i tut ions between the RHCE and RHD genes. The broken l i ne 
i ndicates the deleted region of the RHD gene. 
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The \\ i ld typ equences were a l igned \\ ith the D� A equences obtained and 
\\ e found that the e equences were more do e to the RHCE gene than the RHD 
gen and th is  confi rm the re u l t  obtained [rom the PCR products ge l  electrophore 1 S  























orre pond to the CcEe gene) .  Figure 1 8  sho\ys one samples as an 
crGGGT;';'::::-C;';':�IGGGG-GAGTGGTcrc;.,! ACTTw:;crGAGCAGA;.:G:;'CT:;"� 





• •  . ... . .. ..  · .. ..  • •  __ Jl .. ..  lI • •  � " . ·  • • •  'J! � . "" .- .. .  III . . .. . • ,. • • •  ., . . ... ,, " "' ''' ,. .. . . . .. . ..  ... 
;: eeAT C;' T :;An G. ::rTcrr:GAG: AG1G1T! :;.cr ;.;.;.rrc;.. r ;.ccr:::G.:.;..n;..:..:;c;. 
:::CCATc;..T':;;'TTc;..CTTcrr7G.;GT;.G1GTIT�l;';';'TTc;..T;.ce::: GMTI� 
:::CC;"Tc;.. T � TT C.IT:'c:r: GAGT A':;:':TInG-..'l;';'" ITeAT ;,cc::::GM.r;.;s-..;.,. 
.. . . ... . ... " . .. .. . .. . .. . .. ,. . . ... . . . ... . .. . . .  " . .. . . .. . . . . . . .. . . .. . . . . . .. . . . . ... . ..  . 
en ecrrrr ;'GoG GATT crcr:C;CT;.;.r AI C :A:r "GA,;;,.:;GAGAGAC7C;'::: :-rG'I G1 
CTTccrrIT;':;'G:;;.: :rCTCT:c;..:I;';':;"TCC;.:r;"��G.;crc;..TT;"TGTGT 
c:7 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -






GGG.GT:;:-C ..... !TG;,.T;.:;r;.sr"c;..;.";.sr,,;,,cr;..r·:;.:;c-:Gcc.r;.:;.:;:-c;.;..G::;.,;.;;..s.::;w.:;. 
GGC';GT:;;"j::TT�T';GT���GG.ri.CT;"'T"'�:;C :;"Lr..u;TCMG77�GCW� 
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -���- - - - - - - - - - - - - -��:� 
G:::c;..IT;.;.;,;..;,;.;.:.;.;..;..;..;TA.;Cc-:r.:T:;.:;c-C:;:;.;:;c�..(iG.:;.y"c:c;..�.C1 ;_r�C 
..;...::c:-rr�.;.;.:-MGC,:rr:T:;'GC-CC:-GXGTSG7:;':;c:' c;.;.GCCTST;';' r 
GGT:�- - - - - - - - - - - - - - - - - - - - - -- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Figu re 1 8 :  Sequence a l i gnment of the R H C E, R H O  and the seq uence obtai ned 
for one of the experi mental amp les 
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Chap ter 4 :  Di  c u  IOn 
·t  1 O i  tr ibut ion of A BO Phenotype 
A gene for the spec i fication of  antigen A or B or type 0 deteml ines the blood 
t,) pc. There are D A di [Terence . or pol,)  morphi m . that determi ne the funct ion of 
gil co ,) I tran fera c. re u l t ing in  di fferent ABO blo d types. D istribut ion of ABO 
phenotype and their percentage among 500 local donors of  A l  Ain d istrict were 
determi ned. Data obtai ned b) erological ABO testing ob en'ed i n  Al Ain population 
are gi\ n in  tab 1 1 1 .  There v\ a no signi ficant di fference i n  the d istribution of ABO 
blood group bet\\ een male and female ubject . this i due to the fact that b lood 
group ar auto omal and the frequenc ies are not d i fferent in the two genders (Taha, 
J . y .  ( _ 0 1 2 )) .  
companson of  the d i stribution of  ABO and Rh blood groups in  A l  Ain  
populat ion obtai ned in  the present study with those of everal other studies howed 
ign ificant d i fference in the d i stribution of both ABO and Rh b lood group ant igens. 
In our tudy the ABO blood groups showed that the b lood group 0 was most 
prevalent  fol lowed by group A. R and B. This arrangement in the d istribution of 
ABO groups i s  im i lar to that found in Saudi Arabia and K uwait .  In contrast. the 
comm onest groups in I nd ia  and Pakistan are the blood group 0 and B .  'v\ h i le i n  
E urope the commonest b lood groups are 0 and A.  I n  addit ion, the d istribution of 
d i fferent b lood groups in the present study sho'v\ ed s l ight d i fference in  the percentage 
compared to that of an on ly  document regarding the d istribution of blood groups in  
UAE.  Kalba region ( Taha. J .Y .  ( 2 0 1 2 ) ) .  
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The e finding confi ml that the di  tribution of b lood group in  d i fferent area of 
the \\- orld \ arie \\ hich i perhap due to genet ic d i ffer nees bet\\ e n d ifferent 
popu lat ion . Therefore. i t  i nece ar) to determine the blood group of d i fferent 
geograph ical area . 
Re earch on BO group system ha been of immense i ntere t, due to its 
medical importance in  di fferent d i  ea e .  The BO blood group system is not only 
important in  b lo d transfusion . cardiovascular di sease. organ transplantation. 
erthrobla to i in  neonate . but a lso one of the strongest predictors of national u ic ide 
rate and a genet ic marker of  obesity ( Mo l l iso PL( 1 979) . Hein.  H . .  et a ! .  ( 200 � ) ) .  The 
genetic  h i stor) of a per on can be known by stud) ing the b lood groups ( okolo\' . R .  
( 1 993 ) ) .  And th is  and other facts confi rm the importance of determi nation of the 
prevalence of ABO groups in d i fferent population to meet transfu ion medic ine and 
other field'  requ irement . 
�.2 Di  tr ibut ion of R h  p henotypes 
The studied group consi sted of 500 samples selected from both genders (440 
male and 60 female ) and from different age groups. I n  Rhesus sy tem. our study 
sho\\ prevalence of  Rh po i t ive was 90.4%. \,-,hi l e  only 9.6 % was Rh negative. 
The e fi gures are im i lar to other studies carried in other Asian and African 
countries. The e figures can be a lso compared to that of Europe which shows 
sign ificant d i fference in the d istribution of Rh negative phenotype as shown in table 
1 6 . Thi sugge ts  that the expected frequency of Rh i so- immunization would be 
lower i n  our population than that encountered in the Europe countries. But regarding 
the d istribut ion of  Rh negative among female subjects i t  showed h igher percentage 
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compared to the male. thi can increa e the Percentage of  H D  T in  RhD negati ye 
pregnant \\ omen. 
fhe d i  tributi n of the mo t probable genot) pe that was obtained [1' m the 
phenOL) pe ha be n ho\\ ed in table 1 8 . I t  wa found that there \vere onl) 8 Rh-hr 
mo t probable genotype characterized Al in  population. \\  h i le  the other mo t Rh 
probable genoty pe \\ hich are : Rz R L  Rz R2. r' r'. r 'r". and r"r not found in  this 
studied populat ion.  Thi variat ion can be compared to thi rteen Rh phenotypic groups 
o i' varioLls  frequencie w hich were recorded by Taha. J . Y. in Kalba region. UAE. and 
bou-Jabal . . .  et a l .  2003 i n  Jordan 
The d istribution of Rh phenotype and most probable  genotypes widely range 
among d i Uerent race and re l igions. Our tudy showed that the most frequent 
ant igens among t five major antigens of Rh system was RhD whi l e  the lea t conm10n 
wa E antigen. And regarding the Rh phenotype and most probable genotype it was 
fOLlnd that the most common in Rh posi t ive amples were CCDee and DCe/DCe ( R I  
R d  respect ively .  While  i n  R h  negat ive samples it was cde/cde ( rr ) .  
R l 1  b lood group ystem has vi ta l  role in  population genetics tudy and more 
important ly  i n  t ransfusion practices. Knowledge of Rh phenotypes in  a given 
populat ion i s  re levant for better plan ning and management of b lood banks (AI­
Sheikh.  1 . .  et a 1 .  ( 1 998 ) ) . Pat ients with sickle cel l  d isease. thalassemia, etc, who need 
mul t ip le blood transfusion are not fev in  our region, they may develop al lo­
antibodies against Rh antigens. And to solve this we need to know Rh phenotypes of 
the donors and recipients. Here we recommend that such ident i ficat ion procedures 
prior to transfusion is most v i ta l  in transfusion practice. Such study can be appl ied in  
practice for rapid and effi c ient identi fication of blood donors and immediate 
50 
election of needed compat ib le  b lood unit through formi ng donor pal i nt reoi m e _ 
data ) tern .  
4.3 Determ ina t ion of the  Rh negat ive Variant  
T\\ o gene \\ hich are the RHO and R l ICE located in  the c lose proximit) on 
chromo orne 1 encode the Rh protein . the RhO and RhCE.  The gene are 97 percent 
id ntical ,  each ha 1 0  exon and encode protein that d i ffer by 32 to 35 amino acids.  
The large number of amino ac id d i fference explains why exposure to RhD can result 
in  an immun e  re pon e i n  an RhD-negati \ e  individuals .  These t\\ O genes can encode 
d i fferent yariant that can't be ident i fied erological ly ,  and impOltantly they are 
c l i n ical l )  ign i iicant and have cau ed transfusion fatal i t ies ( Chou, .T  et aL 20 1 0) .  
The d i  tr ibution of  O-negat ive individual worldwide attract the eady attention 
of  population bio logist , \\ ho attempt to make pred ictions of human origins and 
m igrat ions based on Rh phenotype (Caval l i - forza, L L .  ( 1 99 1  ) ) .  It is now obvious 
that the D-negat ive phenotype has arisen numerous t imes on d i fferent genetic 
backgrounds. There are three known mechani sms; which are : the ent i re deletion of 
the RH D gene that occurred on a Dce haplotype ;  that i s. the RHCE al le le  carried 
\\l i th the deletion is ceo The other variants can be a rai sed due to the R H O  that is not 
expressed because of a premature stop codon, nucleotide in ertions, point mutations. 
or R HD/CE hybrids ( H uang, C. ( 1 996 ) & Avent, .D . ,  et at. ( 1 997) ) .  D-negat iye 
phenotypes i n  African and Asian persons are often caused by i nact ive or s i l ent RHO. 
rather that R H O  deletion ( C hang. J .G . . et  al . ( 1 998 )  & Shao. c..  et a l .  ( 2002 ) ). I n  0-
negat ive African b lack persons, 66% have RH D genes that contain a 3 7-bp insert ion, 
which results i n  a premature stop codon, and 1 5% carry a hybrid RH D-CE-O l inked 
to c . tem1cd ceo characterized b) expre Ion of \\ eak 
( ingleton. B . K  .. et al . ( 2000 » ) .  
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and no 0 antigen 
[he fr quenc) or Rh O-negat ive phenot) pe \ aries \" idely in di fferent pan of the 
\\ orld .  Our tud) �ho\\ ed that all of the RhO negali \'e donor have the Cce ce 
phenOl} pe . The Rh ce po i t i \  e phenotypes accounted for 1 .2°'0, and Rhce positive 
account d for 8.4 °'0 of I Ain  studied RhO-negat i ve ubjects.  Ba ed on PCR 
genot) ping a l l  or  the 0 n gat ive ca es in our study showed deletion of intron 4:  
ho\\ ever. that doesn't mean there are no other genetic variation. ddit ional Iy ,  our 
sequence resul t  sho\\ ed ( figure 1 8 ) that most of the PCR product equence match 
to the RHCE gene rather than to R H D  gene. Thi genet ic analysis was confirmed via 
phenotypic anal) i that the e samples "" ere RhD negat ive. 
Thi p i lot  tud} confi rmed not only that the RhD-negat ive phenotype were D­
negat ive but a lso they were RhD negat ive genotypica l ly  where PCR product 
sequences sho\\ ed that the D A samples were 0 negat ive with s imi larity to RHCE 
phenotype. However. the results obtained can't be used to detem1 i ne the type of 
RhD-negat i \'e variants. Molecular assays for blood group genes currenti) rely  on 
pol) mera e chain reaction ( PC R )  ampl ification to generate sufficient material  for 
analy i . One of the most common approaches uses o l igonucleotide primers that are 
sequence spec ific .  with ampl i fications indicat ing the presence or absence of an al lele .  
Another common method i s  PCR restriction fragment length polymorphi sm ( RFLP)  
with primers designed to  ampl ify the  region contain i ng an  a l l e le  s ingle nuc leotide 
polymorphism ( S  P )  fol lowed by d igest ion with a re triction enzyme to detect the 
P. The s ize of the products, as determi ned by e lectrophoresis. ind icate the 
presence or absence of the S P. ( Klein.  H ,  G . . et a J .  (20 1 4d) )  
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v10 lecular te t ing shal l be  combined with serological testing to  lmprO\ e 
transfusion safet) and outcomes. nd the chal lenge i s  to develop automated platform 
that ample e\ eral regions of the gene for unequi \ocaJ interpretat ion.  
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C hapter 5: ConcJu IOn  
I n  a conc lu  ion.  thi� tudy p r  \ ide erologic frequencies of BO and Rh 
phcn t} pe and 1110 t probable gen t) pe in  rder to  ensure safe blood tran fusion i n  
AI  i n  area. And it  \\ i l l  be con idered a a fi r t tud) in  t h i  area u p  t o  our 
�Jl0\\ ledge, v. hi h \\ ould be of great \ a lue for the AE p c ia l l}  Al A in  area as it 
prm ide a reference figure about ABO and Rh-hr ant igens \vhich \\ ould be appl ied 
in b lood tran ' fusion practice . 
The studied group cansi ted of  500 ample e lected from both gender ( 440 
male and 60 female ) and from di fferent age group . I t  was found that the blood 
group 0 \\a pr dominant fol lo\ved by A. B, AB .  And regarding the Rh phenotypes 
it  \Va found that there \\ ere only 8 RJl-hr most probable genotypes characterized A I  
i n  populat ion which are a s  fol lows: R l  1', R l  R L  R l  R2. IT, R 2  r ,  R o  1', R 2  R2, and 
r'r \\ h i l e  the other most Rh probable genotypes \\ hich are :  Rz R L  Rz R2, r'r', r'r", and 
r"r not found in thi studied population. This i variat ion can be compared to thirteen 
RJl phenoty pic group of variou frequenc ies wh ich were recorded by Taha, l Y .  i n  
Kalba region. U E .  
Te t to detemli ne an individual's D status would d ist inguish those RBCs that 
lacks. or ha\'e al tered D epitopes and at risk of immun izat ion to conventional D form 
tho e who carry mutat ions that reduce expression levels of D and are not at risk of 
produci ng ant i -D.  nfortunately.  serologic reagents cannot d iscr iminate between 
these RBCs.  These l im i tat ion suggest that molecular test ing to determi ne D status 
hould be commonplace in  the future . RH mo lecular test ing is an important tool that. 
when combined with serologic methods can resol ve d iscrepanc ies in resu l ts. aid the 
management of hemolyt ic  di sease of newboms and improve transfusion safety and 
54 
outcome for pat ients. The appl ication of molecular genot) ping to tran fu ion 
medic ine has tbe potential to dramatical l)  change blood bank te t ing b) enab l ing tbe 
electronic e lection or  donor units that have been ant igen-matched for rec ipients at 
mul tip le  blood group loc i .  Thi approach should impro\ e pat ient care and transfu ion 
outcome b) reducing a l lo immunization.  The cha l lenge l ies in i ntegrat i ng uch 
te't ing i nto b lood bank. em i ronment. standardiz ing method , obtain ing Food and 
Drug Admin i  lrat ion apprO\ al for labe l ing donor uni ts, and enhanc ing information 
) tern to i ncorporate and u e thi nevI' infOlmation effecti\'e ly .  
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